Phase I trial of NMIL-12-1 in patients with traumatic wounds.

Trial Profile

Phase I trial of NMIL-12-1 in patients with traumatic wounds.

Planning
Phase of Trial: Phase I

Latest Information Update: 30 Apr 2014

At a glance

  • Drugs NMIL 12 1 (Primary)
  • Indications Wound infections
  • Focus Adverse reactions
  • Sponsors Neumedicines
  • Most Recent Events

    • 30 Apr 2014 New trial record
    • 29 Apr 2014 This trial has been recommended for funding by the US Department of Defense, according to a Neumedicines media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top